Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis—an open‐label study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2982|30|3|nmo.13256-nmo.13256

ISSN： 1350-1925

Source： NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol.30, Iss.3, 2018-03, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open‐label pilot study

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1584-1590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open‐label pilot study

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 10, 2015-10 ,pp. : 1584-1590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Usefulness of Intravenous Iron Sucrose in the Management of Preoperative Anemia in Patients with Menorrhagia: A Phase IV, Open-Label, Prospective, Randomized Study

By  

Acta Haematologica, Vol. 121, Iss. 1, 2009-03 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

Phase 1, open‐label, dose escalation, safety, and pharmacokinetics study of ME‐344 as a single agent in patients with refractory solid tumors

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1056-1063

John Wiley & Sons Inc

Access to resources Recommend Favorite

Repetitive dihydroergotamine nasal spray for treatment of refractory headaches: an open-label pilot study

By Weintraub James  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2031-2036

Informa Healthcare

Access to resources Recommend Favorite